Insulet (PODD) stock

Insulin devices , market cap $11B

Insulin infusion devices for diabetes

Market cap $11B

$153.61

+2.63%

As of Monday's close · Live for Pro members at the open

Quality Score

Average

In its industry

#35of 85

Medical Devices

Checks firing

5of 14

Trending down

From 52-week high

-56.7%

Below the 200-day

PODD's Quality Score rose 2 points on Mon, Nov 2, to 7. Buying reached its highest in 20 days (2 chart checks started).

See PODD's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is PODD down?

Down 52% over five years while the S&P 500 rose 76%.

Investors now pay $43 for each $1 of yearly profit, down from $3087 on Nov 1, 2021.

Sources: Price history, Oct 30, 2026; Annual reports, Dec 31, 2025

1 more reason, free with an account →The other side and the timeline, for Pro members.

Key facts on PODD

Key facts on PODD
The company	Sales up 29% on the year
Latest filing	10-Q, Aug 5 Filed its quarterly report (10-Q) for the quarter to Jun 30, 2026

1 more reason behind PODD's 7, free with an account →2 more reasons behind PODD's 7, for Pro members.

PODD in the news

ReportReports Wednesday, before the open. Every 3 months, a company tells everyone how much it sold and earned. It rose after 2 and fell after 2 of its last 4 reports, -5.5% on average. Past reports ›

PODD catalysts

Coming up

After its last 4 reports it closed -5.5% on average, higher 2 of 4 times.

11 past catalysts since 2018, with sizes and sources, for Pro members.Get in free →

Why PODD scores 7

Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means

+5Chart checks 5 of 14 firing right now, one point each
−3Long-term trend below a falling 200-⁠day average, down over one year, down over two years

Size adds
Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.

No effect today: Run-up, Dilution, Volatility, Cash flow, Persistence, News, and Insider trades.

What every line is worth, and the reason behind it, on PODD and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:40 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when PODD's Quality Score turns up

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on PODD and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

PODD has 5 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on PODD, and all 14 on every stock.Get in free →

PODD RSI today: 67.2, above its 50-day, below its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1467.2
Above 50, below 70.
MACD (12, 26, 9)Above signal
Crossed above its signal line 19 sessions ago.
50-day average$141.02
The price is 8.9% above it.
200-day average$178.13
The price is 13.8% below it.
50/200 crossDeath cross
The 50-day crossed below the 200-day on Jan 20.
ADX 1426.1
25 or more, with +DI above -DI.
Support$152.78
Swing low from Jul 9, 0.5% below the price.
Resistance$155.17
Swing high from Aug 19, 1.0% above the price.
52-week high$354.88
From Nov 20, 2025, 131.0% above the price.
52-week low$126.40
From Aug 5, 17.7% below the price.
Chart patternNone
No triangle, channel, or wedge in the last year.
Bollinger Bands (20, 2)Inside
The bands run from $129.89 to $155.91.
Volume1.3x
Against its 20-day average, for the time of day.

The deep dive on PODD

What it does and how it makes money5 findings"As of December 31, 2025, we had over 1,000 patents in the United States and certain other countries, with expiration dates ranging from 2026 through 2047 and had over 700 patent applications pending." (10-K for fiscal 2025)SEC filing · Feb 18, 2026
Where it stands3 findingsFor Pro members3 findings on where PODD stands: its cash, debt, and share count, for Pro members
What changed in its filings5 findings"The Court’s April 24, 2025 post-trial orders upheld the jury verdict and entered a permanent injunction against Defendants; to avoid any double recovery with the injunction, the district court also reduced the damages of the award to $ 59.4 million." (10-Q for the quarter to Jun 30, 2026)SEC filing · Aug 5, 2026A new heading in its "Risk Factors" this year: "Expansion of U.S. tariffs could have a material adverse effect on our financial results." (10-K for fiscal 2025; not in fiscal 2024's)SEC filing · Feb 18, 2026, against the one of Feb 21, 2025One distributor made up 27% of its revenue in fiscal 2025, down from 28% in fiscal 2024; another made up 25%, up from 21% in fiscal 2024.SEC filing · Feb 18, 2026
Who holds and trades it4 findingsFor Pro members4 findings on who holds and trades PODD, for Pro members
Against its closest peers1 peerSales over four quarters against a year before: PODD +29%, DXCM +16%.

13 more findings on PODD, each with its source, for Pro membersGet in free →

How PODD ranks in Medical Devices

PODD is #35 of 85 by Quality Score.

How PODD ranks in Medical Devices
1	ATRCAtriCure	7/14	18
2	HAEHaemonetics	7/14	17
3	WSTWest Pharmaceutical Services	6/14	17
	PENPenumbra		Open for its score
	PLSEPulse Biosciences		Open for its score
	PRCTPROCEPT BioRobotics		Open for its score
	QTEXQTREX Quantum		Open for its score
35	PODDInsulet	5/14	7

Sales over four quarters against a year before: PODD +29%, DXCM +16%.

When does PODD report earnings, and what happens after?

Reports Wed Nov 4, before the open (in 2 days). Confirmed.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

+4.8%-9.7%-20.1%

Feb 18May 6Aug 5

Reported	When	Gap	Reaction	5 sessions
Aug 5, 2026Before open	Before open	-23.3%	-20.1%	-13.3%
May 6, 2026Before open	Before open	-0.3%	-9.7%	-5.5%
Feb 18, 2026Before open	Before open	+8.0%	+4.8%	-0.4%

PODD closed higher after 2 of its last 4 reports.

All 4 reports, and PODD's Quality Score going into each

Everyone reporting earnings this week

PODD sales and profit by year

Sales and profit by year

Sales grew every year from 2016 to 2025, to $2.7B. It made a profit in six of the eight years.

Insiders trading PODD

PODD insider trades

3 insiders bought $1.1M across 3 filings, and one insider sold $60K across 1 filing, in the last 6 months. The newest:

BuyAshley McEvoy$162KPresident and CEOat $147.47 on Aug 21, filed Aug 24

BuyAshley McEvoyPresident and CEO$162Kat $147.47 on Aug 21, filed Aug 24

All 4 insider filings on PODD from the last six months, for Pro members.Get in free →

All PODD insider trades

PODD trades by Congress and the executive branch

27 trades disclosed in the last six months. The newest:

BuyDonald Trump$15K to $50KPresident (R)traded Aug 28, disclosed Oct 8(41 days later)

BuyDonald TrumpPresident (R)$15K to $50Ktraded Aug 28, disclosed Oct 8(41 days later)

All 27 trades on PODD disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

PODD's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Ashley McEvoyPresident and CEO · 2 trades
Flavia PeaseEVP & CFO
Eric BenjaminEVP and COO
John W. KapplesSVP and General Counsel
Laetitia CousinSVP, Reg, Quality & Compliance
Lauren BuddenGroup VP, CAO and Controller
Lisa Blair DavisSVP, Chief HR Officer
Michael PanosEVP and CCO

13 more officers and directors file at PODD. Each page above names the rest.

See insider trades by person

Which ETFs hold PODD?

In ETFs: PODD is under 0.1% of SCHG, under 0.1% of VOO, and under 0.1% of IVV, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Aug 31, 2026.

About Insulet

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

5,400 employeesActon, MAinsulet.com

What Insulet says it competes with

“The diabetes medical device market is highly competitive, subject to rapid change, and significantly affected by new product introductions.”

From its annual report, SEC filing · Feb 18, 2026

2 more sentences, what it says it does, and its sales by region, for Pro membersGet in free →

PODD's score card

Insulet (PODD): Quality Score 7, Average, #35 of 85 in Medical Devices, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn PODD's score around: 5 things
1 more filing explained, a plain line each
Real-⁠time prices, no delay

BreakawayOct 8Donald Trump bought PODD$15K to $50K, disclosed Oct 8

Alerts are optional.

See PODD's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 2, 2026: PODD's Quality Score is 7 (Average), #35 of 85 in Medical Devices. Insiders bought $1.1M and sold $60K in the last 6 months (Form 4).

Is PODD a good stock to buy? What its Quality Score says

PODD scores 7 today, which Breakaway calls Average. It is #35 of 85 in Medical Devices by Quality Score, with 5 of 14 chart checks firing. Down 52% over five years while the S&P 500 rose 76%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is PODD's Quality Score?

PODD scores 7 today, which Breakaway calls Average (6 to 10). That is #35 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind PODD's 7.

Are insiders buying PODD?

3 insiders bought $1.1M across 3 filings, and one insider sold $60K across 1 filing, in the last 6 months. The newest is Ashley McEvoy, President and CEO, who bought $162K on Aug 21. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.